비교리스트

 카트 문의
시장보고서
상품코드
1375863

심혈관 중재시술 기기 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 지역별, 부문별 예측(2023-2030년)

Interventional Cardiology Devices Market Size, Share & Trends Analysis Report By Product (Coronary Stents, PTCA Balloon Catheters, Accessory Devices), By Region, And Segment Forecasts, 2023 - 2030
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

심혈관 중재시술 기기 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 심혈관 중재시술 기기 시장 규모는 2030년까지 223억 5,000만 달러에 달할 전망입니다.

심장혈관 중재시술 시장은 2023-2030년 연평균 7.2%의 성장률을 보일 것으로 예상됩니다. 관상동맥 중재시술에 대한 유리한 보험급여 정책, 세계 심혈관질환(CVDs) 및 당뇨병 유병률 증가, 중재적 심장병학 장비의 신제품 출시 등으로 인해 중재적 심장병학 장비에 대한 수요가 증가 추세입니다. 심혈관 질환은 세계 사망률과 이환율의 주요 원인 중 하나입니다. 관상동맥질환과 선천성 심장질환은 세계에서 유행하는 주요 심혈관 질환입니다.

또한 흡연, 좌식생활, 부적절한 식습관 등 건강에 해로운 생활습관도 당뇨병의 원인으로 꼽히고 있습니다. 심장 카테터 치료, 혈관 성형술, 경피적 관상동맥 중재술(PCI)은 심혈관 질환을 치료하는 데 사용되는 주요 시술 중 하나입니다. 당뇨병은 심혈관 질환을 유발하는 주요 원인 중 하나이기 때문에 당뇨병 환자 증가는 예측 기간 중 중재적 심장학 장비에 대한 수요를 급증시킬 것으로 예상됩니다. 시장은 향후 수년간 확대될 것으로 예상되지만, 특히 보험 적용이 부족한 신흥 경제 국가에서 의료기기의 높은 가격으로 인해 성장이 둔화될 수 있습니다.

심혈관 중재시술 기기 시장 보고서 하이라이트

  • 관상동맥 스텐트 분야가 2022년 매출 점유율 64.6%로 시장 독점. 관상동맥 스텐트 부문에서는 DES가 매출의 대부분을 차지합니다.
  • 분지형 스텐트 개발, 생분해성 재료 사용 등 관상동맥 스텐트의 기술적 발전은 CVD 치료의 효율성과 치료 결과를 향상시키고 있습니다. 각 업체들은 제품 개발, 파트너십 및 전략적 제휴에 적극적으로 나서고 있습니다. 앞서 언급한 요인으로 인해 예측 기간 중 업계 성장이 촉진될 것으로 예상됩니다.
  • 아시아태평양은 예측 기간 중 가장 빠른 CAGR 7.9%로 성장할 것으로 예상됩니다. 이러한 성장은 관상동맥질환(CAD)의 발병률 증가와 이 질환에 대한 선별 조치의 개선 등 몇 가지 요인에 기인합니다.
  • 시장은 여러 기업이 존재하기 때문에 파편화되어 있습니다. 따라서 향후 수년간 경쟁이 심화될 것으로 예상됩니다. 시장 진출기업은 시장에서의 입지를 강화하기 위해 제휴, 영업 및 마케팅 활동, M&A, 서비스 확장, 통합 제공, 제품 출시 등 다양한 전략적 구상을 채택하고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 심혈관 중재시술 기기 시장 변수, 동향, 범위

  • 시장 계통 전망
    • 모시장 전망
    • 관련/부수 시장 전망
  • 보급과 성장 전망 매핑
  • 시장 역학
    • 시장 촉진요인 분석
    • 시장 억제요인 분석
  • 심장 인터벤션 디바이스 시장 분석 툴
    • 업계 분석 - Porter's Five Forces
    • PESTEL 분석

제4장 심혈관 중재시술 기기 시장 : 제품 추정·동향 분석

  • 심혈관 중재시술 기기 시장 : 주요 포인트
  • 심혈관 중재시술 기기 시장 : 제품 동향과 시장 점유율 분석, 2022년 및 2030년
  • 관상동맥 스텐트
  • PTCA 풍선 카테터
  • 액세서리 디바이스
  • 혈관내 이미징 카테터 및 압력 가이드와이어

제5장 심혈관 중재시술 기기 시장 : 지역 추정·동향 분석

  • 지역별 전망
  • 지역별 심혈관 중재시술 기기 시장 : 주요 포인트
  • 북미
    • 북미 시장 추산·예측, 2018-2030년
    • 미국
    • 캐나다
  • 유럽
    • 유럽 시장 추산·예측, 2018-2030년
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 스웨덴
    • 노르웨이
    • 덴마크
  • 아시아태평양
    • 아시아태평양 시장 추산·예측, 2018-2030년
    • 일본
    • 중국
    • 인도
    • 호주
    • 태국
    • 한국
  • 라틴아메리카
    • 라틴아메리카 시장 추산·예측, 2018-2030년
    • 브라질
    • 멕시코
    • 아르헨티나
  • 중동 및 아프리카
    • MEA 시장 추산·예측, 2018-2030년
    • 사우디아라비아
    • 남아프리카공화국
    • 아랍에미리트
    • 쿠웨이트

제6장 경쟁 구도

  • 주요 시장 참여 기업에 의한 최근 동향과 영향 분석
  • 시장 참여 기업의 분류
    • Abbott Laboratories
    • Medtronic
    • Boston Scientific
    • Spectranetics
    • Cardinal Health
    • Philips Healthcare
    • Terumo
    • Alvimedica
    • Teleflex Medical
    • B. Braun
    • Biosensors International
    • Meril Life Sciences
    • BIOTRONIK
    • ACIST Medical Systems
    • ASAHI INTECC
    • CID Vascular
    • Cook Medical
    • Medinol
    • Merit Medical Systems
    • NuMED
    • OpSens
    • Vascular Solutions
    • Zeon Medical
KSA 23.11.15

Interventional Cardiology Devices Market Growth & Trends:

The global interventional cardiology devices market size is expected to reach USD 22.35 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 7.2% from 2023 to 2030 Demand for interventional cardiology devices is on the rise owing to favorable reimbursement policies for coronary intervention procedures, rising prevalence of cardiovascular diseases (CVDs) and diabetes across the globe, and the launch of new product lines in the market. Cardiovascular diseases have become one of the major causes of mortality and morbidity in the world. Coronary artery disease and congenital heart defects are the major cardiovascular diseases that are prevalent across the globe.

Furthermore, the adoption of unhealthy lifestyles, such as smoking, a sedentary lifestyle, and improper diet, is responsible for diabetes. Cardiac catheterization, angioplasty, and Percutaneous Coronary Intervention (PCI) are some of the major procedures used for the treatment of cardiovascular diseases. Since diabetes is one of the major reasons behind triggering cardiovascular diseases, increasing diabetes cases are expected to surge the demand for interventional cardiology devices over the forecast period. Although the market is anticipated to expand over the coming years, it might witness slower growth possibly brought on by the high price of medical devices, especially in developing economies with insufficient insurance coverage.

Interventional Cardiology Devices Market Report Highlights:

  • The coronary stents segment dominated the market with the largest revenue share of 64.6% in 2022. DES makes up the majority of sales in the coronary stent category.
  • Technological advancements in coronary stents, such as the development of bifurcated stents and the use of biodegradable materials, have led to efficient and improved outcomes of CVD treatment. Companies are proactively involved in product developments and partnerships and strategic collaborations. The aforementioned factors are expected to propel industry growth over the forecast period
  • Asia Pacific region is expected to advance at the fastest CAGR of 7.9% over the forecast period. This growth can be attributed to several factors, including the increasing incidence of coronary artery disease (CAD) and improved screening measures for this disorder.
  • The market is fragmented due to the presence of several players. This is expected to intensify the competition in the coming years. Market players are adopting various strategic initiatives such as partnerships, sales & marketing activities, mergers & acquisitions, service expansion, integrated offerings, and product launches to increase their market presence

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Interventional Cardiology Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Interventional Cardiology Devices Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Interventional Cardiology Devices Market: Product Estimates & Trend Analysis

  • 4.1. Interventional Cardiology Devices Market: Key Takeaways
  • 4.2. Interventional Cardiology Devices Market: Product Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Coronary Stents
    • 4.3.1. Coronary stents market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.2. DES
      • 4.3.2.1. DES market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.3. BMS
      • 4.3.3.1. BMS market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.4. BRS
      • 4.3.4.1. BRS market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. PTCA Balloon Catheters
    • 4.4.1. PTCA balloon catheters market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Normal
      • 4.4.2.1. Normal market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Specialty
      • 4.4.3.1. Specialty market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.4. DCB
      • 4.4.4.1. DCB market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Accessory Devices
    • 4.5.1. Accessory devices market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.2. PTCA guidewires
      • 4.5.2.1. PTCA guidewires market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.3. Diagnostic catheters
      • 4.5.3.1. Diagnostic catheters market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.4. PTCA guiding catheters
      • 4.5.4.1. PTCA guiding catheters market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.5. Introducer sheaths
      • 4.5.5.1. Introducer sheaths market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Intravascular imaging catheters and pressure guidewires
    • 4.6.1. Intravascular imaging catheters and pressure guidewires market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Interventional Cardiology Devices Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. Interventional Cardiology Devices Market by Region: Key Takeaways
  • 5.3. North America
    • 5.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. UK
      • 5.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. Germany
      • 5.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. France
      • 5.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Italy
      • 5.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Spain
      • 5.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Norway
      • 5.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.9. Denmark
      • 5.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. Japan
      • 5.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. China
      • 5.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. India
      • 5.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Australia
      • 5.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. Thailand
      • 5.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.7. South Korea
      • 5.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Brazil
      • 5.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Mexico
      • 5.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.4. Argentina
      • 5.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. Saudi Arabia
      • 5.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. South Africa
      • 5.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. UAE
      • 5.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.5. Kuwait
      • 5.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Market Participant Categorization
    • 6.2.1. Abbott Laboratories
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. Medtronic
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Boston Scientific
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Spectranetics
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Cardinal Health
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Philips Healthcare
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Terumo
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Alvimedica
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. Teleflex Medical
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives
    • 6.2.10. B. Braun
      • 6.2.10.1. Company overview
      • 6.2.10.2. Financial performance
      • 6.2.10.3. Product benchmarking
      • 6.2.10.4. Strategic initiatives
    • 6.2.11. Biosensors International
      • 6.2.11.1. Company overview
      • 6.2.11.2. Financial performance
      • 6.2.11.3. Product benchmarking
      • 6.2.11.4. Strategic initiatives
    • 6.2.12. Meril Life Sciences
      • 6.2.12.1. Company overview
      • 6.2.12.2. Financial performance
      • 6.2.12.3. Product benchmarking
      • 6.2.12.4. Strategic initiatives
    • 6.2.13. BIOTRONIK
      • 6.2.13.1. Company overview
      • 6.2.13.2. Financial performance
      • 6.2.13.3. Product benchmarking
      • 6.2.13.4. Strategic initiatives
    • 6.2.14. ACIST Medical Systems
      • 6.2.14.1. Company overview
      • 6.2.14.2. Financial performance
      • 6.2.14.3. Product benchmarking
      • 6.2.14.4. Strategic initiatives
    • 6.2.15. ASAHI INTECC
      • 6.2.15.1. Company overview
      • 6.2.15.2. Financial performance
      • 6.2.15.3. Product benchmarking
      • 6.2.15.4. Strategic initiatives
    • 6.2.16. CID Vascular
      • 6.2.16.1. Company overview
      • 6.2.16.2. Financial performance
      • 6.2.16.3. Product benchmarking
      • 6.2.16.4. Strategic initiatives
    • 6.2.17. Cook Medical
      • 6.2.17.1. Company overview
      • 6.2.17.2. Financial performance
      • 6.2.17.3. Product benchmarking
      • 6.2.17.4. Strategic initiatives
    • 6.2.18. Medinol
      • 6.2.18.1. Company overview
      • 6.2.18.2. Financial performance
      • 6.2.18.3. Product benchmarking
      • 6.2.18.4. Strategic initiatives
    • 6.2.19. Merit Medical Systems
      • 6.2.19.1. Company overview
      • 6.2.19.2. Financial performance
      • 6.2.19.3. Product benchmarking
      • 6.2.19.4. Strategic initiatives
    • 6.2.20. NuMED
      • 6.2.20.1. Company overview
      • 6.2.20.2. Financial performance
      • 6.2.20.3. Product benchmarking
      • 6.2.20.4. Strategic initiatives
    • 6.2.21. OpSens
      • 6.2.21.1. Company overview
      • 6.2.21.2. Financial performance
      • 6.2.21.3. Product benchmarking
      • 6.2.21.4. Strategic initiatives
    • 6.2.22. Vascular Solutions
      • 6.2.22.1. Company overview
      • 6.2.22.2. Financial performance
      • 6.2.22.3. Product benchmarking
      • 6.2.22.4. Strategic initiatives
    • 6.2.23. Zeon Medical
      • 6.2.23.1. Company overview
      • 6.2.23.2. Financial performance
      • 6.2.23.3. Product benchmarking
      • 6.2.23.4. Strategic initiatives
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제